Gender dimorphisms in progenitor and stem cell function in cardiovascular disease

Area of Science:

• Cardiovascular Science
• Stem Cell Biology
• Endocrinology

Background:

• Cardiovascular disease outcomes show significant gender disparities, partly due to sex steroids.
• Gender differences are also observed in progenitor and stem cell roles for cardiac and vascular repair.
• Understanding these sex-based influences is crucial for improving clinical outcomes and cell therapy efficacy.

Purpose of the Study:

• To review the cardiovascular effects of key sex steroids (estradiol, testosterone).
• To discuss the therapeutic potential of endothelial progenitor cells, mesenchymal stem cells, and embryonic stem cells.
• To examine the direct impact of sex steroids on these stem cell types for regenerative medicine.

Main Methods:

• Literature review of studies on sex steroids and cardiovascular health.
• Analysis of research on stem cell therapies for myocardial and endothelial regeneration.
• Synthesis of findings on sex steroid modulation of progenitor and stem cell function.

Main Results:

• Sex steroids significantly impact cardiovascular function and repair mechanisms.
• Endothelial progenitor cells, mesenchymal stem cells, and embryonic stem cells show promise in cardiovascular repair.
• Sex steroids directly influence the function and survival of these stem cell populations.

Conclusions:

• Sex differences in cardiovascular disease are linked to sex steroids and stem cell behavior.
• Hormonal milieu and donor gender critically affect stem cell therapy outcomes.
• Targeting sex steroid pathways may enhance stem cell-based cardiovascular regeneration.